Menu
1-702-720-6310 info@microcapspecualtors.com

Amicus Therapeutics: Is This Biotech an Orphan Underdog? – Motley Fool


Motley Fool

Amicus Therapeutics: Is This Biotech an Orphan Underdog?
Motley Fool
One of the hottest areas to invest in biotech is the “orphan” sector. Orphan diseases, as defined by the FDA, are medical conditions that affect fewer than 200,000 people within the U.S. Due to the nature of these underserved indications, the FDA has …

and more »

Search